NAVELLIER & ASSOCIATES INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$418,000
-12.7%
3,532
-1.0%
0.06%
-15.3%
Q3 2021$479,000
-20.2%
3,568
-3.7%
0.07%
-20.0%
Q2 2021$600,000
+100.0%
3,706
-0.8%
0.09%
+66.7%
Q1 2021$300,000
+47.8%
3,7360.0%0.05%
+45.9%
Q4 2020$203,0003,7360.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders